Skip to main content
SpringerLink
Log in

Therapeutic Applications of Ion Exchange Resins

  • Chapter
  • First Online:
Ion Exchange Technology II

Abstract

Ion exchange resins (IER) are water insoluble, cross-linked, chemically inert and free from local and systemic side effects. Copolymers based on vinyl, divinyl benzene and polystyrene having extensive charged functional sites have extensive binding sites leading to very high drug-loading ability. The ability of IER to bind to drug helps in masking the bitter taste of drug, drug release, drug stabilization, etc. and has made it a popular choice with pharmaceutical companies. Some IER are used as disintegrants due to their rapid water uptake. It also helps in stabilization of drug which otherwise will deteriorate on storage. Thus, IER can be used to overcome various pharmaceutical problems. IER have also found applications in parenteral drug delivery, site-specific drug delivery, as gastric retentive systems. Site-specific drug delivery is important for cancer treatment. Chewing gums also act as mobile drug delivery system specifically for treating dental caries, smoking cessation, etc. These versatile applications of IER are being used for various therapeutic applications such as neutralizing the gastric juices (hyperacidity) in treatment of gastric ulcer, Na and K supplement/depletion in oedema of cardiac, hepatic, pancreatic and nephritic origin, i.e. in a condition of Na and water retention of cardiac failure, hepatic diseases (cirrhosis of liver), pancreatic, toxaemia of pregnancy and nephritic origin. Cation-exchange resins (CER) have been used to reduce phosphate in renal end-stage disease, also as adjuvant in the treatment of hyperkalaemia associated with oliguria/anuria secondary to ARF. Anion-exchange resins (AER) have also been used in treatment of hyperglycaemia, treatment of high cholesterol level, drug-binding defects in uraemia, to reduce penicillin G binding.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kasture AV, Wadodkar SG, Mahadik KK, More HN (2002) A textbook of pharmaceutical analysis and instrumental methods, 8th edn. Pierce Scientific, Rockford, pp 39–47

    Google Scholar 

  2. Bhalekar M, Avari JG, Jaiswal SB (2004) Cation-exchanger in pharmaceutical formulation. Indian J Pharm Sci 38:184–187

    Google Scholar 

  3. Mantell CL (1951) Ion-exchangers. In: Adsorption. McGraw-Hill, New York, pp 185–216

    Google Scholar 

  4. Adams BA, Holmes EL (1935) Synthetic ion-exchange resins. J Soc Chem Ind 54:1T

    Article  Google Scholar 

  5. Hughes L, Ion-exchange resin unique solution to formulation problem; pharmaceutical technology Excipients and solid dosage form 2004. http://www.pharmtech.com/

  6. Chaubal MV (2006) Synthetic polymer based ion-exchange resin. Drug Del Technol 2006:6–8

    Google Scholar 

  7. (a) Segal HL, Hodge H, Watson JS, Scott WJ (1945) The influence of anion exchange resins on experimentally produced oral drugs Gostroenlerology 4:484. (b) Dock W (1946) Trans Assoc Am Phys 59:282

    Google Scholar 

  8. Chaudhary NC, Saunders L (1956) Sustained release of drugs from ion-exchange resins. J Pharm Pharmacol 8:975–986

    Article  Google Scholar 

  9. Keating JW (1961) Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith. US Patent 2,990,332

    Google Scholar 

  10. Hays EE (1961) Pharmaceutical compositions containing a resin narcotic compound. US Patent 3,035,979

    Google Scholar 

  11. Jain NK (2005) Advanced drug delivery system, 1st edn. Antares, CBS Publication. pp 290–302

    Google Scholar 

  12. Pisal S, Zainnuddin R, Nalawade P, Mahadik K, Kadam S (2004) Molecular property of Ciprofloxacin–Indion 234 complexes. AAPS Pharm Sci Tech 5:62–63

    Google Scholar 

  13. Pisal S, Zainnuddin R, Nalawade P, Mahadik K, Kadam S (2004) Drug released property of polyethylene–glycol treated ciprofloxacin–Indion234 complexes. AAPS Pharm Sci Tech 5(4):64

    Google Scholar 

  14. Payne WW (1956) Ion-exchange resins in clinical medicine. J Pharm Pharmacol 8:397–402

    Article  CAS  Google Scholar 

  15. Witzman JL (1996) Drug used in the treatment of hyperlipoproteinemias. In: Hardman JG, Limbird LE (eds) Goodman & Gilman’s the pharmacological basis of therapeutics, pp 875–897

    Google Scholar 

  16. Hussain MA, Diluccio RC et al (1989) Hollow fibres as an oral sustained release delivery system. Pharm Res 6:49–52

    Article  CAS  Google Scholar 

  17. Moreau JM, Green LC, Engel LS, Hill JM, O’Callaghan RJ (1998) Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model. Curr Eye Res 17(8):808–812

    Article  CAS  Google Scholar 

  18. Suh B, Craig WA, England AC, Elliot RL (1981) Effect of free fatty acids on protein binding of antimicrobial agents. J Infect Dis 143:609–616

    Article  CAS  Google Scholar 

  19. Jani R, Gan O, Ali Y, Rodstrom R, Hancock S (1994) Ion-exchange resins for ophthalmic delivery. J Ocul Pharmacol 10(1):57–67

    Article  CAS  Google Scholar 

  20. Hughes L, Gehris A, A new method of characterizing the buccal dissolution of drug. Rohm and Haas Research Laboratory Spring House, Philadelphia http://www.rohmhaas.com/ionexchange/pharmaceuticals/Formulations_doc/buccal_dissolution.pdf

  21. Van Abbe NJ, Rees JT (1998) An approach for development of oral sustained release suspension. J Am Pharm Assoc Sci 47:487

    Article  Google Scholar 

  22. Douglas SJ (1963) Drug adsorbates. US Patent 5,219,563

    Google Scholar 

  23. Sheumaker JL (1998) Liquid prolonged released pharmaceutical formulation containing ionic constituent. US Patent 4,762,709

    Google Scholar 

  24. Akkaramonkolporn P (2001) Molecular property of propranolol HCl prepared in drug resin complex. Drug Dev Ind Pharm 27:359–364

    Article  Google Scholar 

  25. Raghunathan Y (1980) Prolong released pharmaceutical preparations. US Patent 4,221,778

    Google Scholar 

  26. Sriwangjanya M, Bodmeier R (1998) Effect of ion–exchange resin on drug released from matrix tablet. Pubmed 46(3):321–327. Bellamy SA, Hughes L (2003) Method for the anhydrous loading of nicotine onto ion-exchange resins. US Patent 6,607,752

    Google Scholar 

  27. Litchenckert S, Landgren C, Ferno O (1975) Chewable smoking substitute composition. US Patent 3,901

    Google Scholar 

  28. Kurowski M et al (1994) The efficacy and relative bioavailability of diclofenac resinate in rheumatoid arthritis patients. Int J Clin Pharmacol Ther 32:433–440

    CAS  Google Scholar 

  29. Amsel LP, Hinsvark ON, Rotenberg K et al (1984) Recent advances in sustained release technology using ion-exchange polymers. Pharm Technol 8:28–48

    CAS  Google Scholar 

  30. Sayed UG, Bajaj AN (2000) Oral controlled release bromhexine ion-exchange resinate suspension formulation. Indian Drugs 37:185–189

    CAS  Google Scholar 

  31. Yan Chen, Gray BN (1999) Controlled released preparation for cytotoxic or cytostatic drug. US Patent 5,307,162

    Google Scholar 

  32. Fell TJ, Conitehead L, Collett JH (2000) Prolonged gastric retention using floating dosage forms. Pharm Technol 24:82–88

    CAS  Google Scholar 

  33. Atyabi F, Sharma HL, Mohammad HAH (1996) Controlled drug release from coated floating ion-exchange resin beads. J Control Release 42:25–28

    Article  CAS  Google Scholar 

  34. Irwin WJ et al (1974) Drug delivery by ion-exchange Part VII: release of acidic drugs from AniKo, H. and Royer, M.E., In vitro binding of drugs to Colestipol hydrochloride. J Pharm Sci 63:1914–1920

    Article  Google Scholar 

  35. Burton S et al (1995) Intragastric distribution of ion exchange resins: a drug delivery system for the topical treatment of the gastric mucosa. J Pharm Pharmacol 47:901–906

    Article  CAS  Google Scholar 

  36. Sawaya A et al (1987) Binding mechanism of doxorubicin in ion exchange albumin microcapsules. J Pharm Sci 76:475–480

    Article  CAS  Google Scholar 

  37. Narisawa S et al (1994) An organic acid induced sigmoidal release system for oral controlled release preparations. Pharm Res 11:111–116

    Article  CAS  Google Scholar 

  38. Narisawa S et al (1994) An organic acid-induced sigmoidal release for oral controlled release preparations. 2. Permeability enhancement of Eudragit RS coating led by the physicochemical interactions with organic acid. J Pharm Sci 85:184–188

    Article  Google Scholar 

  39. Chen Y et al (1991) Evaluation of ion-exchange microspheres as carriers for the anticancer drug Doxorubicin: in-vitro studies. J Pharm Pharmacol 44:211–215

    Article  Google Scholar 

  40. Li VHK et al (1987) Influence of drug properties and routes of drug administration on the design of sustained and controlled release systems. In: Robinson JR, Lee VHL (eds) Controlled drug delivery, Marcel Dekker, New York. pp 3–94

    Google Scholar 

  41. Cheng YH, Watts P, Hinchcliffe M, Hotchkiss R, Nankervis R, Faraj NF, Smith A, Davis SS, Illum L (2002) Development of a novel nasal nicotine formulation comprising an optimal pulsatile and sustained plasma nicotine profile for smoking cessation. J Control Release 79:243–254

    Article  CAS  Google Scholar 

  42. Bellamy, Simon A, Hughes L (2003) Method for the anhydrous loading of nicotine onto ion-exchange resins. US Patent 6,607,752

    Google Scholar 

  43. Sriwangjanya M, Bodmeier R (1998) Effect of ion-exchange resin on drug released from matrix tablet. Pubmed 46(3):321–327

    Google Scholar 

  44. Pandit JK, Singh S, Muthu MS (2006) Controlled released formulation in neurology practice. Ann Indian Acad Neurol 9:207–216

    Article  Google Scholar 

  45. Zemp HN (1983) Anionic ion-exchange resins with cholesterol decreasing properties. US Patent 4,393,145

    Google Scholar 

  46. Kunin R (1988) Blood cholesterol reducing pharmaceutical composition. US Patent 5,840,339

    Google Scholar 

  47. Naumann G, Pieper G, Rehberg H-J (1976) Dental composition and appliances containing anti-carious ion-exchange resin. US Patent 3,978,206

    Google Scholar 

  48. Tatsuya S, Kenzo O, Yoshimasa I, Noriaki M, Kentaro W, Shoko F, Hiroko Y, Motoshi O, Kazunari S, Yoshiaki K, Hiroshi N (2007) Colestimide lowers plasma glucose levels and increases plasma glucagon-like peptide-1 (7–36) levels in patients with type 2 diabetes mellitus complicated by hypercholesterolemia. J Nippon Med Sch 74(5):338–343

    Article  Google Scholar 

  49. Gilpin JA, Patric J, Roger A (1983) Adsorption and recovery of rifamycine B and rifamycine S using basic ion-exchange resins. US Patent 4,402,877

    Google Scholar 

  50. Martz BL, Kohlstaedt KG, Helmer OM (1952) Use of anion and cation exchange resins in odemea. Circulation 5:524–533

    Article  CAS  Google Scholar 

  51. Craig WA, Evenson MA, Sarver KP, Wagnild JP (1976) J Lab Clin Med 87:637

    CAS  Google Scholar 

  52. Lichtenwalner DM, Suh B, Lorber B, Rudnick MR, Craig WA (1981) J Lab Clin Med 97:72

    CAS  Google Scholar 

  53. Jay A, Miers JR (1995) Regulation of ion exchange resins for the food, water and beverage industries Reactive Polymers 24:99–107

    Google Scholar 

Download references

Acknowledgements

The authors are thankful to the Department of Anatomy, JNMC, Aligarh, for generous support.

Author information

Authors and Affiliations

  1. Department of Anatomy, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, 202002, India

    Fazal-Ur-Rehman

  2. Department of Biochemistry, Aligarh Muslim University, Aligarh, 202002, India

    Sheeba Nuzhat Khan

Authors
  1. Fazal-Ur-Rehman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sheeba Nuzhat Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fazal-Ur-Rehman .

Editor information

Editors and Affiliations

  1. Faculty of Engineering & Technology, Department of Applied Chemistry, Aligarh Muslim University, Aligarh, 202 002, India

    Dr. Inamuddin

  2. College of Engineering, Chemical Engineering Department, King Saud University, Riyadh, Saudi Arabia

    Mohammad Luqman

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Fazal-Ur-Rehman, Khan, S.N. (2012). Therapeutic Applications of Ion Exchange Resins. In: Inamuddin, D., Luqman, M. (eds) Ion Exchange Technology II. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4026-6_7

Download citation

Publish with us

Policies and ethics

Search

Navigation